Douglas E. Jones
Net Worth

Last updated:

What is Douglas E. Jones net worth?

The estimated net worth of Mr. Douglas E. Jones is at least $2,101,175 as of 28 Oct 2024. He owns shares worth $202,695 as insider and has received compensation worth at least $1,898,480 in Neogen Corporation.

What is the salary of Douglas E. Jones?

Mr. Douglas E. Jones salary is $474,620 per year as Vice President & Chief Commercial Officer in Neogen Corporation.

How old is Douglas E. Jones?

Mr. Douglas E. Jones is 55 years old, born in 1970.

What stocks does Douglas E. Jones currently own?

As insider, Mr. Douglas E. Jones owns shares in one company:

Company Title Shares Price per share Total value
Neogen Corporation (NEOG) Vice President & Chief Commercial Officer 36,131 $5.61 $202,695

What does Neogen Corporation do?

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Douglas E. Jones insider trading

Neogen Corporation

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 15,504 $13.81 $214,110
Option
Restricted Stock Units 15,504 $13.81 $214,110
Option
Common Stock 784 $14.43 $11,313
Option
Restricted Stock Units 784 $14.43 $11,313
Option
Restricted Stock Units 12,939 $15.07 $194,991
Option
Common Stock 12,939 $15.07 $194,991
Option
Restricted Stock Units 46,512 $15.48 $720,006
Option
Common Stock (Right to Buy) 179,550 $15.48 $2,779,434
Purchase
Common Stock 10,000 $15.17 $151,730
Purchase
Common Stock 2,500 $17.91 $44,775
Option
Restricted Stock Units 37,133 $13.28 $493,126
Option
Common Stock (Right to Buy) 165,105 $13.28 $2,192,594
Purchase
Common Stock 7,000 $14.31 $100,170
Option
Common Stock (Right to Buy) 22,086 $28.4 $627,242
Option
Restricted Stock Units 4,225 $28.4 $119,990
Purchase
Common Stock 1,400 $35.78 $50,092
Option
Common Stock (Right to Buy) 24,717 $9.71 $240,002
Option
Restricted Stock Units 3,917 $40.85 $160,009

Neogen key executives

Neogen Corporation executives and other stock owners filed with the SEC: